Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 28.6%GRADE not reported 0 · 0%Very low 4 · 57.1%Low 1 · 14.3%Moderate 0 · 0%High 0 · 0%

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

Global state: No clinically important response (as defined by the original studies) · patients with schizophrenia

It is very uncertain whether COMPARISON 5. ARIPIPRAZOLE changes global state: No clinically significant response compared with OLANZAPINE (very low certainty).

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
RR 1.06 [0.96, 1.17]
11 studies · 1739 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

Mental state: as · patients with schizophrenia

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 1500 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

Leaving the study early · patients with schizophrenia

COMPARISON 5. ARIPIPRAZOLE may leads to higher leaving the study early compared with OLANZAPINE (low certainty).

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
RR 1.15 [1.05, 1.25]
9 studies · 2331 participants
Low

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

Quality of life: as · patients with schizophrenia

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

Weight gain · patients with schizophrenia

It is very uncertain whether COMPARISON 5. ARIPIPRAZOLE changes adverse effects: weight gain compared with OLANZAPINE (very low certainty).

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
RR 0.25 [0.15, 0.43]
9 studies · 1538 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

General functioning ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

COMPARISON 1. ARIPIPRAZOLE vs OLANZAPINE

Service use ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found